Authors:
Rimmelzwaan, GF
Baars, M
van Amerongen, G
van Beek, R
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses, VACCINE, 20(1-2), 2001, pp. 158-163
Authors:
de Jong, JC
Heinen, PP
Loeffen, WLA
van Nieuwstadt, AP
Claas, ECJ
Bestebroer, TM
Bijlsma, K
Verweij, C
Osterhaus, ADME
Rimmelzwaan, GF
Fouchier, RAM
Kimman, TG
Citation: Jc. De Jong et al., Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy, VACCINE, 19(31), 2001, pp. 4452-4464
Authors:
Rimmelzwaan, GF
de Jong, JC
Bestebroer, TM
van Loon, AM
Claas, ECJ
Fouchier, RAM
Osterhaus, ADM
Citation: Gf. Rimmelzwaan et al., Antigenic and genetic characterization of swine influenza A (H1N1) virusesisolated from pneumonia patients in the Netherlands, VIROLOGY, 282(2), 2001, pp. 301-306
Citation: Jtm. Voeten et al., Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells, CLIN EXP IM, 125(3), 2001, pp. 423-431
Authors:
Rimmelzwaan, GF
Nieuwkoop, N
Brandenburg, A
Sutter, G
Beyer, WEP
Maher, D
Bates, J
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM (TM) vaccines and conventional vaccines, VACCINE, 19(9-10), 2000, pp. 1180-1187
Citation: Jtm. Voeten et al., Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activationof specific CD8(+) cytotoxic T lymphocytes, VACCINE, 19(4-5), 2000, pp. 514-522
Authors:
de Jong, JC
Beyer, WEP
Palache, AM
Rimmelzwaan, GF
Osterhaus, ADME
Citation: Jc. De Jong et al., Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly, J MED VIROL, 61(1), 2000, pp. 94-99
Authors:
Fouchier, RAM
Bestebroer, TM
Herfst, S
Van der Kemp, L
Rimmelzwaan, GF
Osterhaus, ADME
Citation: Ram. Fouchier et al., Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene, J CLIN MICR, 38(11), 2000, pp. 4096-4101
Authors:
Barnett, JM
Cadman, A
Gor, D
Dempsey, M
Walters, M
Candlin, A
Tisdale, M
Morley, PJ
Owens, IJ
Fenton, RJ
Lewis, AP
Claas, ECJ
Rimmelzwaan, GF
De Groot, R
Osterhaus, ADME
Citation: Jm. Barnett et al., Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, ANTIM AG CH, 44(1), 2000, pp. 78-87
Citation: Jtm. Voeten et al., Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes, J VIROLOGY, 74(15), 2000, pp. 6800-6807
Authors:
Rimmelzwaan, GF
Baars, M
van Beek, R
de Lijster, P
de Jong, JC
Claas, ECJ
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., Influenza virus subtype cross-reactivities of haemagglutination inhibitingand virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine, VACCINE, 17(20-21), 1999, pp. 2512-2516
Authors:
Voeten, JTM
Brands, R
Palache, AM
van Scharrenburg, GJM
Rimmelzwaan, GF
Osterhaus, ADME
Claas, ECJ
Citation: Jtm. Voeten et al., Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium, VACCINE, 17(15-16), 1999, pp. 1942-1950
Authors:
Rimmelzwaan, GF
Claas, ECJ
van Amerongen, G
de Jong, JC
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus, VACCINE, 17(11-12), 1999, pp. 1355-1358
Authors:
Karlas, JA
Siebelink, KHJ
van Peer, MA
Huisman, W
Cuisinier, AM
Rimmelzwaan, GF
Osterhaus, ADME
Citation: Ja. Karlas et al., Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challengeinfection, J GEN VIROL, 80, 1999, pp. 761-765